Why choose ID? This article highlights perspectives from incoming infectious diseases pharmacy residents, exploring what inspired them to pursue the field—ranging from intellectual curiosity and clinical impact to a passion for antimicrobial stewardship and patient care. It also shares their advice for future trainees, emphasizing perseverance, mentorship, and staying open to opportunities along the journey.

Article Drafting Started 21 March 2026
MORE ADDITIONS WILL BE ADDED IN THE COMING DAYS/WEEKS AS SUBMISSIONS ARE PROCESSED. WANT TO PARTICIPATE? DM ME OR USE OUR CONTACT PAGE HERE!
Match Day for Phase 1 of the 2026–2028 pharmacy residency cycle took place on Wednesday, March 18, 2026—marking the arrival of a new cohort of pharmacists preparing to begin infectious diseases (ID) training.
According to data from ASHP, there are 142 ID residency programs, of which 86 (61%) participated in Phase 1 of the Match (the remaining 56 programs filled their positions early).
Across all programs, 156 total positions were available. Of these, 65 positions (42%) were filled prior to the Match, leaving 91 positions to be filled during Phase 1. Post-Match data show that 72 of those 91 positions were filled, while 18 remained listed as unfilled (assuming 1 positions dropped out there b/c the math is off).
Overall, 138 of the 156 positions (88%) have now been filled, leaving 18 open positions that will likely move into Phase 2 of the Match.
If you know of anyone going to phase 2, we have these articles that you might share with them:
- Top 10 Tips For Pharmacy Residency Match Phase 2
- Preparing For Phase 2 Of The Pharmacy Residency Match
As a fun way to welcome the newest group of ID enthusiasts to what I’d argue is the best specialty out there, I thought it would be great to highlight a few of them and ask some questions. It’s always fascinating to hear what draws people to infectious diseases—and just as valuable to learn what advice these incoming residents have for those hoping to follow in their footsteps.
Through referrals from friends and a call for participation on social media, I had the chance to connect with some truly incredible individuals featured in this post. I hope you find their perspectives insightful—and that it brings a smile to your face.
Here are some of our future ID pharmily members…
Garrett Shepard, PharmD.

1. Where are you headed for your ID PGY2 residency?
University of Michigan, to complete a 2-year Infectious Diseases Clinical and Translational Research Fellowship
2. Why did you choose ID?
I chose ID because no two patients are ever the same. Each case feels like assembling a complex puzzle, integrating clinical presentation, microbiology, pharmacology, and patient-specific factors to arrive at the best therapeutic approach. That process is both intellectually challenging and deeply fulfilling. In many ways, practicing in ID feels like a constant chess match against evolving pathogens, requiring anticipation, adaptability, and lifelong learning. It’s a field that keeps you humble, curious, and engaged every single day.
3. What advice do you have for future pharmacists considering an ID PGY2?
If you are considering a career in ID, I strongly encourage you to pursue an ID rotation, ideally both as a student and during residency. Use those experiences to reflect on what truly excites you. Ask yourself: Which specialty made me want to dig deeper, read more, and understand the “why” behind every decision? If you find yourself “nerding out” over antibiograms, culture data, and antimicrobial stewardship strategies, then ID may be the right fit for you. Additionally, be proactive and seek out mentors in ID, stay curious, and don’t be intimidated by the complexity of the field. The learning curve is steep, but that’s part of what makes it so rewarding.
Maricela M. Moreno Martinez, Pharm.D.

1. Where are you headed for your ID PGY2 residency?
Baptist Health South Florida Corporate Pharmacy Enterprise ID PGY2
2. Why did you choose ID?
Aside from ID being the best specialty, I was drawn to the ability to truly cure patients. There’s something rewarding about treating an infection and seeing a patient recover and go home well. I also love the complexity of ID; it’s like solving a puzzle. You have to piece together clinical data, microbiology, and pharmacology to find the right answer.
On a more personal note, growing up in a Hispanic household, antibiotics were sometimes (always) treated like a cure-all. Being able to now educate my family and my patients on appropriate use and why stewardship matters is really meaningful (and occasionally a battle at home). It’s a great reminder of how impactful our role can be beyond the hospital setting.
3. What advice do you have for future pharmacists considering an ID PGY2?
Do it! Practice is completely different from the classroom, in the best way. It’s more dynamic, more engaging, and honestly a lot more fun. You’re constantly learning, being challenged, and growing every day. You’ll also meet and work with people from all backgrounds and experiences, which makes the field even more rewarding.
More coming soon!
Disclaimer: All respondents voluntarily participated in this activity. The views and opinions expressed in this article represent the individual and does not necessarily reflect the policy or position of any past, present, or potential future employer. ChatGPT was used for content drafting and clarity enhancements.
RECOMMENDED TO YOU


